home
portfolio
team
careers
contact
investor portal

home
portfolio
team
careers
contact
investor portal

Autolus Therapeutics to Report First Quarter 2022 Financial Results and Host Conference Call on May 5

Autolus Therapeutics to Report First Quarter 2022 Financial Results and Host Conference Call on May 5

Post navigation

Previous PostPrevious Black Diamond Therapeutics Announces Pipeline Prioritization and Workforce Realignment

Next PostNext FDA Grants Regenerative Medicine Advanced Therapy (RMAT) designation to Autolus’ CAR T cell therapy, obe-cel, for the treatment of adult B-ALL

Search for:

Recent Comments

Archives

Categories

No categories

Meta

Log in
Entries feed
Comments feed
WordPress.org

© Nextech Invest Ltd. | privacy policy | legal notices